[
  {
    "text": "(d) Phase IV Optional: Upon mutual written agreement of University and ArTara, ArTara may sponsor, and University may",
    "bbox": [
      239,
      81,
      1000,
      94
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "conduct, new Product or Product-related clinical studies (for example, follow-up studies) to support the goal of the Project or",
    "bbox": [
      272,
      96,
      1000,
      109
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "as may be useful for gaining or maintaining Regulatory Approvals for the Product for the Indication. Any such studies will be",
    "bbox": [
      273,
      113,
      1000,
      125
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "at the sole discretion of each Party subject to terms and conditions to be mutually agreed upon in agreements separate from",
    "bbox": [
      273,
      129,
      1000,
      141
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "this Agreement. Richard Smith, MD will be given first consideration as a principal investigator for all new Product or Product-",
    "bbox": [
      273,
      145,
      1000,
      157
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "related clinical studies, in addition to other sites provided final site selection will be based on the best interest of the Project..",
    "bbox": [
      272,
      161,
      1000,
      173
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "(e)",
    "bbox": [
      240,
      178,
      273,
      188
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": " Phase V: Publication: Collected data from the Project will be used to write a paper by the University and/or Principal",
    "bbox": [
      266,
      176,
      1000,
      189
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Investigator (the \"Publication') as a follow up to the publication in 2009 (Smith MC, Zimmerman MB, Burke DK, Bauman.",
    "bbox": [
      272,
      192,
      1000,
      205
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "NM, Sato Y, Smith RJ; OK-432 Collaborative Study Group. Efficacy and safety of OK-432 immunotherapy of lymphatic",
    "bbox": [
      270,
      208,
      1000,
      221
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "malformations. Laryngoscope. 2009Jan;119(1):107-15. doi: 10.1002/lary.20041. PubMed PMID: 19117316). (the",
    "bbox": [
      272,
      224,
      1000,
      237
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "\"Publication'). The Publication will be in accordance with the terms in Article 5 herein.",
    "bbox": [
      272,
      239,
      920,
      253
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "2.3 Project Management. During the term of this Agreement, the Principal Investigator and and/or his authorized representative and ArTara",
    "bbox": [
      111,
      257,
      1000,
      269
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "authorized representatives will meet as necessary to consult with one another and discuss the progress and results of the Project and any",
    "bbox": [
      111,
      273,
      1000,
      285
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "modifications to the Project Plan. Consultation by either Party shall be by means of personal visits, correspondence and telephone calls, all as",
    "bbox": [
      111,
      289,
      1000,
      301
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "appear reasonable and necessary and are mutually agreed upon by the Principal Investigator and ArTara.",
    "bbox": [
      110,
      304,
      900,
      318
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "ARTICLE THREE",
    "bbox": [
      597,
      321,
      733,
      332
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "FUNDING AND PAYMENT",
    "bbox": [
      563,
      337,
      769,
      347
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "3.1 Funding. During the term of the Project in accordance with the Project Plan, ArTara will provide thirty thousand dollars (US $30,oo0) per year in",
    "bbox": [
      112,
      353,
      1000,
      365
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "funding for the Project, taking into consideration the time spent by University employees required for the Project. The Parties agree to discuss in",
    "bbox": [
      112,
      369,
      1000,
      381
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "good faith potential additional funding required for completion of the Project as applicable and necessary..",
    "bbox": [
      113,
      385,
      904,
      397
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "3.2 Approval Milestone based on Data Value: Within forty-five (45) days of an approval of the TARA-002 BLA by the FDA, ArTara will pay a one-",
    "bbox": [
      112,
      401,
      1000,
      413
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "time approval milestone to University pursuant to the usefulness of the Program Data in TARA-o02's BLA filing, as set forth below:",
    "bbox": [
      111,
      417,
      1000,
      428
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Official Feedback from FDA regarding the Program Data",
    "bbox": [
      116,
      435,
      554,
      448
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Milestone",
    "bbox": [
      912,
      434,
      991,
      449
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "***...]",
    "bbox": [
      137,
      454,
      192,
      469
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "I$",
    "bbox": [
      914,
      456,
      932,
      468
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "...***...]",
    "bbox": [
      927,
      455,
      996,
      468
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "... ***...]",
    "bbox": [
      119,
      475,
      191,
      490
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "$[... ***...]",
    "bbox": [
      912,
      475,
      997,
      491
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "...***...]",
    "bbox": [
      118,
      495,
      193,
      512
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "$[... ***...]",
    "bbox": [
      912,
      495,
      998,
      512
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "[... ***...]",
    "bbox": [
      118,
      516,
      192,
      532
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "...***...",
    "bbox": [
      922,
      518,
      987,
      531
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "5",
    "bbox": [
      662,
      554,
      674,
      565
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Source: ARTARA THERAPEUTICS, INC., 8-K, 1/10/2020",
    "bbox": [
      133,
      1000,
      570,
      1000
    ],
    "label": 15,
    "category": "Termination For Convenience"
  }
]